NanoValent continues to progress towards its goal of moving our lead drug candidate to an IND/BLA and the clinic in 2021 and 2022. Although our “almost virtual” infrastructure has us sheltering-in-place as a regular course of business, these are by no means normal times.  Yet,...

Berwyn, PA – DEC. 24, 2019 – CuRAGE Therapeutics announced today that it is scheduled to deliver a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Dr. Ihor Terlecky...

Privately-held Pacylex may have a gem in its pipeline. Pacylex is developing PCLX-001, a first-in-kind, small molecule with a novel mechanism of action believed to play a significant role in the development of certain types of blood cancers and solid tumors. Data from four dif...

In the world of pharmaceutical product development, an effective drug to treat Alzheimer's disease (AD) is the Holy Grail. Very little has been successful in this area to date. Neurodegenerative diseases remains a difficult area for new product development and Alzheimer's by f...

UGI employees continued a long-standing tradition of giving back to the community throughout the holiday season. UGI employees have shared their spirit of the season in a variety of activities that support a wide range of community organizations across Pennsylvania in providin...

As families and businesses gather to celebrate the holiday season, UGI encourages all members of the community to remember the following energy-related safety tips: Practice good safety habits when using a natural gas oven and stove.  If you use natural gas for cooking, be sur...

Proprietary discovery and engineering platform to develop precision phage therapies First phage candidate expected to enter the clinic in 2022 Pipeline of antimicrobial-resistance and microbiome applications Estimated $12 Billion addressable market for multi-drug resistant in...

In the latest Emerson College/WHDH National Poll of the Democratic Primary, former Vice President Joe Biden leads at 32%, followed by Senator Bernie Sanders at 25%. Senator Elizabeth Warren comes in third at 12%, followed by Mayor Pete Buttigieg at 8%, and entrepreneur Andrew ...

Dec. 17th 2019 -- Abimmune BioPharma today announced that it has scheduled a company presentation at Biotech Showcase™ 2020 to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Flora Fang, MD., PhD, the company Founde...

OTTAWA, Ontario, December 17, 2019 – GaN Systems today announces that SPARX Group "Mirai Creation Fund II (“Mirai fund”)" has made an investment in GaN Systems. Mirai fund provides capital to companies with the goal of accelerating innovation, Vehicle Electrification being one...